These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33825723)

  • 1. [Randomized study of tolerability, safety and efficacy of Pletax in intermittent claudication].
    Kazantsev AN; Goriunov SV; Ershova OB; Erofeeva SB; Gurgenian EV
    Angiol Sosud Khir; 2021; 27(1):7-16. PubMed ID: 33825723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilostazol for intermittent claudication.
    Bedenis R; Stewart M; Cleanthis M; Robless P; Mikhailidis DP; Stansby G
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD003748. PubMed ID: 25358850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study of efficacy and safety of Aducil in patients with chronic lower limb ischaemia].
    Suchkov IA; Kalinin RE; Gadzhimuradov RU; Lar'kov RN; Uchkin IG; Chupin AV; Parshin PI; Kamaev AA; Porsheneva EV
    Angiol Sosud Khir; 2019; 25(3):29-37. PubMed ID: 31503245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of cilostazol and pentoxifylline for treating intermittent claudication.
    Dawson DL; Cutler BS; Hiatt WR; Hobson RW; Martin JD; Bortey EB; Forbes WP; Strandness DE
    Am J Med; 2000 Nov; 109(7):523-30. PubMed ID: 11063952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
    Beebe HG; Dawson DL; Cutler BS; Herd JA; Strandness DE; Bortey EB; Forbes WP
    Arch Intern Med; 1999 Sep; 159(17):2041-50. PubMed ID: 10510990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF; Davie AM; Clegg JP
    Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review the efficacy and safety of cilostazol, pentoxifylline, beraprost in the treatment of intermittent claudication: A network meta-analysis.
    Liang X; Wang Y; Zhao C; Cao Y
    PLoS One; 2022; 17(11):e0275392. PubMed ID: 36318524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.
    Money SR; Herd JA; Isaacsohn JL; Davidson M; Cutler B; Heckman J; Forbes WP
    J Vasc Surg; 1998 Feb; 27(2):267-74; discussion 274-5. PubMed ID: 9510281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
    Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial.
    Dawson DL; Cutler BS; Meissner MH; Strandness DE
    Circulation; 1998 Aug; 98(7):678-86. PubMed ID: 9715861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC; Moher D; Barber GG
    CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.
    Regensteiner JG; Ware JE; McCarthy WJ; Zhang P; Forbes WP; Heckman J; Hiatt WR
    J Am Geriatr Soc; 2002 Dec; 50(12):1939-46. PubMed ID: 12473004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of withdrawal of drugs treating intermittent claudication.
    Dawson DL; DeMaioribus CA; Hagino RT; Light JT; Bradley DV; Britt KE; Charles BE
    Am J Surg; 1999 Aug; 178(2):141-6. PubMed ID: 10487267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the assessment of the efficacy of pentoxifylline (Trental).
    Rössner M; Müller R
    J Med; 1987; 18(1):1-15. PubMed ID: 3298515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent claudication: a double-blind crossover trial of pentoxifylline.
    Gallus AS; Gleadow F; Dupont P; Walsh J; Morley AA; Wenzel A; Alderman M; Chivers D
    Aust N Z J Med; 1985 Aug; 15(4):402-9. PubMed ID: 3866536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
    Lee TM; Su SF; Tsai CH; Lee YT; Wang SS
    Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trental 400 in the treatment of intermittent claudication: results of long-term, placebo-controlled administration.
    Roekaerts F; Deleers L
    Angiology; 1984 Jul; 35(7):396-406. PubMed ID: 6380348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of cilostazol, a novel phosphodiesterase inhibitor in patients with intermittent claudication.
    Samra SS; Bajaj P; Vijayaraghavan KS; Potdar NP; Vyas D; Devani RG; Ballary C; Desai A
    J Indian Med Assoc; 2003 Sep; 101(9):561-2, 564. PubMed ID: 15168999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydration may reverse most symptoms of lower extremity intermittent claudication or rest pain.
    Parodi JC; Fernandez S; Moscovich F; Pulmaria C
    J Vasc Surg; 2020 Oct; 72(4):1459-1463. PubMed ID: 32972591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilostazol: a novel treatment option in intermittent claudication.
    Cariski AT
    Int J Clin Pract Suppl; 2001 Apr; (119):11-8. PubMed ID: 11355274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.